C.V. Parvin Dehghan. Director & head of Mycology and Parasitology Dep. ( ) Faculty of Medicine, Isfahan University of Medical Sciences

Similar documents
Introduction. Study of fungi called mycology.

Voriconazole. Voriconazole VRCZ ITCZ

Antifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences

Management of fungal infection

C.V. Address: Medical Mycology Department, Pasteur Institute of Iran, Thran. Iran

Update zu EUCAST 2012 Cornelia Lass-Flörl

neoplasms chemotherapy AIDS acquired immunodeficiency syndrome mycotoxins allergens Fungal infections opportunisitic pathogens accidental phenomenon

Oslo meeting May 21st 2014

Table 1. Antifungal Breakpoints for Candida. 2,3. Agent S SDD or I R. Fluconazole < 8.0 mg/ml mg/ml. > 64 mg/ml.

About the Editor Gerri S. Hall, Ph.D.

Abstract. Mohamad Reza Nazer (1) Bahareh Golpour (2) Mahdi Babaei Hatkehlouei (3) Masoud Golpour (4)

AUSTRALIAN ANTIFUNGAL SUSCEPTIBILITY DATA : PART 2 THE MOULDS ASPERGILLUS, SCEDOSPORIUM AND FUSARIUM.

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

number Done by Corrected by Doctor د.حامد الزعبي

Antifungal resistance mechanisms in pathogenic fungi

Opportunistic Mycoses

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Use of Antifungal Drugs in the Year 2006"

Antifungal therapies differences in agents

Antifungal Pharmacotherapy

Case presentations: The pitfalls in diagnosis and management of oral lesions in cancer patients

CANDIDIASIS (WOMEN) Single Episode. Clinical Features. Diagnosis. Management

number Done by Corrected by Doctor

In Vitro Interactions of Antifungal agents and Tacrolimus against Aspergillus Biofilms

SYNERGISTIC ACTIVITIES OF TWO PROPOLIS WITH AMPHOTERICIN B AGAINST SOME AZOLE-RESISTANT CANDIDA STRAINS. PART II

Antifungal drugs Dr. Raz Muhammed

Common Fungi. Catherine Diamond MD MPH

How Can We Prevent Invasive Fungal Disease?

Coleophoma empetri FR901379, Fig. 1, ,,, 1,3- -D-glucan. . C. albicans A. fumigatus. Dixon plot C. albicans A. fumigatus 1,3- -D-glucan

, Aspergillus A. terreus. 4 Candida albicans. 2 Otomycosis. , Histoplasmosis Paracoccidiomycosis

ISHAM Symposium: S33: Ocular aspects of Fungal Infections Friday, 8 May 2015, ; MR101/102 Level 1

Antifungal Activity of Voriconazole on Local Isolates: an In-vitro Study

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Rank Title SJR 5026 Journal of Nephropathology Banach Journal of Mathematical Analysis Iranian Journal of Pharmaceutical

An Update in the Management of Candidiasis

Dr Hamed Alzoubi. Fungal infections

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

ﺖاﻀﻴﺒﻤﻠا ﺾﻴﺒﻠا ﻦﻤزﻤﻠا ﻰﻠﻋ ﺔﻴﺸﻐأﻠا ﺔﻴﻄاﺨﻤﻠا

SCY-078 ECMM Symposium Cologne, Germany October 2017

Summary of the risk management plan (RMP) for Cresemba (isavuconazole)

International Journal of Health Sciences and Research ISSN:

Ali Alabbadi. Sarah Jaar ... Nader

Mycobacteria and fungal infections of the respiratory tract

Use of Antifungals in the Year 2008

ANA ESPINEL-INGROFF* Division of Infectious Diseases, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia

Voriconazole Rationale for the EUCAST clinical breakpoints, version March 2010

Antifungals and current treatment guidelines in pediatrics and neonatology

ACADEMIC STAFF PROFESSIONAL PROFILE FORM

Cigna Drug and Biologic Coverage Policy

Condition First line Alternative Comments Candidemia Nonneutropenic adults

CD101: A Novel Echinocandin

Title: Author: Speciality / Division: Directorate:

Candida albicans 426 (64.0 ) C. albicans non-albicans

FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS- NEW WORDS ABOUT OLD ISSUE

Mycotic Keratitis in Patients Attending a Tertiary Care Hospital

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017

Fungal Infection Pre-Infusion Data

Antifungal Pharmacodynamics A Strategy to Optimize Efficacy

number Done by Corrected by Doctor

Infectious diseases are one of the most common causes of morbidity and mortality in humans. Development of antibiotic therapy has resulted in

In vitro cross-resistance between azoles in Aspergillus fumigatus: a reason for concern in the clinic?

dida tropicalis, Candida parapsilosis, Candida krusei, Cr. neoformans

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION

Fungi Presence In Africanized Honeybees Hives Affected By Brazilian Sac Brood

1. Pre-emptive therapy. colonization, colonization, pre-emptive therapy. , ICU colonization. colonization. 2, C. albicans

TEPZZ Z9Z74_A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION

Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH]

The incidence of invasive fungal infections

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory ZODERM E CREAM. Oxiconazole Nitrate Cream

Mycological Profile of Bronchial Wash Specimens in Patients with Lower Respiratory Tract Infections

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology

ANTIMYCOTIC DRUGS Modes of Action

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

Deep Dermatophytosis

Aflatoxin in Food: What Role for Biotechnology?

EUCAST-AFST Available breakpoints 2012

Worldwide dispersion of Candida auris: a multiresistant and emergent agent of candidiasis

February [KU 1014] Sub. Code: 4705

Japan Antifungal Surveillance Program (1):

Antifungal Susceptibility Testing

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

Fungal Infection Post-Infusion Data

Received 18 December 2008/Returned for modification 9 February 2009/Accepted 9 April 2009

APX001 A novel broad spectrum antifungal agent in development for the treatment of invasive fungal infections

Egyptian Dermatology Online Journal Vol. 6 No 2: 3, December 2010

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

PREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI

Prevalence and Management of Non-albicans Vaginal Candidiasis

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

herbmed.skums.ac.ir In vitro comparison of the effect of honey and clotrimazole against Candida albicans isolated from vagina

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN VORICONAZOLE ORION 200 MG FILM-COATED TABLETS

Archives of Infect Diseases & Therapy, 2017

Resistance epidemiology

High incidence of onychomycosis due to saprophytic fungi in Yazd, Iran

International Journal of Health Sciences and Research ISSN:

New Antifungal Can Fight Candida, Aspergillus.(Infectious Diseases): An Article From: Internal Medicine News [HTML] [Digital] By Damian McNamara

Transcription:

C.V Parvin Dehghan Faculty of Medicine, Isfahan University of medical Sciences, Iran. dehghan@med.mui.ac.ir Professional Experience Director & head of Mycology and Parasitology Dep. (2014-2016) Faculty of Medicine, Isfahan University of Medical Sciences Associate Professor of Mycology & Parasitology Department Faculty of Medicine, Isfahan University of medical Sciences, Iran. Lecturer (Academic Member) for courses of Medical mycology in medicine, dentistry, pharmacy, laboratory sciences (28 years). Faculty of Medicine, Isfahan University of Medical Sciences, Iran. Education PhD (2002-2007) Medical Mycology Tehran University of Medical Sciences & Sydney University. The Thesis: DNA Typing of A.flavus strains isolated from referral patients which identified by conventional methods; introducing a suitable and definite way of identification these isolates. M.S.C (1985-1988) Medical Mycology Tehran University of Medical Sciences The MS Thesis: Isolation of sporothrix schenckii in Patients suspected to cutaneous leishmaniasis) B.S.C (1980-1984) Laboratory Sciences, Isfahan University, Iran.

Academic Publications 1. Antifungal Susceptibility of Candida Species Isolated from Cancer Patients with Oral Lesions Undergoing Chemotherapy. International Journal of Infection. 2017 (In Press). 2. Investigating the performance of drug delivery system of fluconazole made of nano micro fibers coated on cotton/polyester fabric Journal of Materials Science: Materials in Medicine 2017 3. The matching rate of the frequency of the isolated Candida species calculated by morphological and molecular methods in patients with vaginitis. Journal of Isfahan Medical School2017 4. Frequency of Cutaneous Fungal Infections and Azole Resistance of the Isolates in Patients with Diabetes Mellitus. Advanced Biomedical Research. 2017;6. 5. Identification of Candida species isolated from candiduria patients using PCR-RFLP in Isfahan, Iran, Journal of Isfahan Medical School, 2017. 6. The frequency of oral candidiasis in children and adolescents with leukemia in Isfahan province, Iran Journal of Isfahan Medical School, 2017. 7. Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole. Advanced biomedical research. 2016;5. 8. Interdigital intertrigo due to Fusarium oxysporum. Current Medical Mycology. 2016;2(1):43-6. 9. Determination of antifungal susceptibility patterns among the environmental isolates of Aspergillus fumigatus in Iran. Advanced biomedical research. 2016;5. 10. Identification of Candida species in the oral cavity of diabetic patients. Current Medical Mycology. 2016;2(2):1-7. 11. The effect of cyclophosphamide on TLR2 gene expression in Balb /C mice with systemic candidiasis, Journal of Isfahan Medical School, 2016. 12. Comparative study of the urinary level of aflatoxin M1 in patients with hepatitis C virus (HCV) and healthy people. Journal of Isfahan Medical School. 2016; 34(404):1275-81. 13. Identification of clinical isolates of Candida using Duplex- PCR, 2016. 14. Identification of morphological and molecular Aspergillus species isolated from patients based on beta-tubulin gene sequencing. Yafte. 2017; 19(1).

15. Identification of Candida Species in Oral Cavity of Smokers and Nonsmokers, Journal of Isfahan Medical School Vol. 33, No. 362, 2nd Week, February 2016. 16. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.Antimicrobial Agents and Chemotherapy January 2016 Volume 60 Number 1. 17. Specific identification of candida glabrata by colorimetric assay based on gold nanoparticle. Journal of Isfahan Medical School 2015. 18. Cutaneous mucormycosis in an iguana. Online Journal of Veterinary Research 2015. 19. -Prevalence of Fungal Keratitis in Patients with Corneal Ulcer Journal of Isfahan Medical School 2015. 20. Antifungal Activity of Anethum Graveolens Extract and Atrovastatin against Candida Species Compared to Fluconazole, Journal of Isfahan Medical School 2015. 21. Multilocus variable-number tandem-repeat analysis of clinical isolates of Aspergillus flavus from Iran reveals the first cases of Aspergillus minisclerotigenes associated with human infection. BMC Infectious Diseases 2014. 22. Antifungal Effect of Echinophora Platyloba Essence against the Candida Species Isolated from Vulvovaginal Candidiasis, Compared with Fluconazole Journal of Isfahan Medical School 2014. 23. The Concentration of Aflatoxin M1 in the Mothers Milk in Khorrambid City, Fars, Iran Advanced Biomedical Research 2014. 24. Enumeration and identification of dust fungal elements from the weather inversion phenomenon in Isfahan, Iran. Advanced Biomedical Research, 2014. 25. Prevalence of Ochratoxin A in Human Milk in the Khorrambid Town, Fars Province, South of Iran. Jundishapur J Microbio, July 2014. 26. The Epidemiology of Dermatophytosis among Elementary School Children in Koohrang City, Iran, in 2014 and 2015, Journal of Isfahan Medical School, Vol. 33, No. 352, 4th Week, November 2015. 27. Diagnosis of Candida Species Isolated from Patients with Vaginal Candidiasis and Healthy Individuals Based on Clinical Symptoms and Paraclinical Evidences. Journal of Isfahan Medical School, December 2012.

28. Detection of aflr gene and toxigenicity of Aspergillus flavus group isolated from patients with fungal sinusitis. Iranian J Pub Health, 2008. 29. Aflatoxin and sclerotia production in clinical isolates of Aspergillus flavus group Iranian J Pub Health. 37(2):41-5, 2008. 30. A case of verrucous carcinoma overridding an old eumycetoma. Archives of Iranian Medicine,5(1);59-60,2002. 31. The incidence of opportunistic fungi in patients suspected of tuberculosis.mycoses, vol 43,269-272, 2000. 32. The therapeutic effects of Itraconazole on 50 cases of dermatophytosis in Isfahan.Journal of Isfahan medical school vol 18, No 59 autumn 2000. 33. The use of certain cereals in preparation of culture media for growth and identification of the fungi. Journal of Isfahan medical school, 2000. 34. Primary cutaneous Aspergillosis due to Aspergillus niger. ACTA. MEDICA. IRANICA. 29, 25-37, 1987. 35. The prevalence and etiology of dermatophytoses in Isfahan, Iran. Mycoses 5(6), 1997. 36. Survey of lesions suspected to pityriasis versicolor in Isfahan, Iran, Pajuheshname, 1993. 37. Report of a cutaneous nocardiosis in Isfahan. J. of Amuzesh and Darman1993. Projects under Supervision 1. Identification and determination of the frequency of Candida species in the narcotic and stimulants smokers, mouth in Isfahan, using PCR- RFLP method.2017. 2. Identification of etiologic agents of candiduria using PCR-RFLP method and determination of MIC of fluconazole and amphotericin B of isolates by microdilution broth, 2017. 3. Bio-resonance effects of fluconazole, nystatin and amphotericin B drugs on clinical isolates of Candida (, albicans krusei, Glabrata).2017 4. The survey of Mutations in CYP51A gene among the clinical and environmental isolates of Aspergillus fumigatus to Azoles 2016. 5. The study of urinary levels of aflatoxin M1 in patients with HCV and healthy subjects.2016.

6. Prevalence of Candida dubliniensis among clinical isolates of Candida albicans/ dubliniensis complex in diabetic patients by Duplex- PCR.2016. 7. Frequency of cutaneous fungal infections in diabetic patients along with antifungal effects of the isolates to some antifungals. 2015. 8. The effect of Cyclophosphomide in the gene expression of TLR2 and IL10 and IL17 in balb/c mice with systemic candidiasis 2015. 9. Frequency of Candida species isolated from the mouth of smokers and diabetic patients in Sanandaj hospitals by PCR RFLP method compare to control individuals, 2015. 10. Identification of Candida species in patients with oral lesion undergoing chemotherapy along with MIC to fluconazole (2014). 11. Identification and frequency of Candida sp. isolated from the mouth in smokers and diabetic patients in Sannandaj hospitals by PCR RflP method compare to control individuals (2014). 12. Specific identification of Candida glabrata by colorimetric assay based on gold nanoparticles (2013). 13. Comparison of IL-12 levels produced bypbmc from normal cases before and after stimulation with different species of Candida in-vitro (2013). 14. Antifungal Activity of Anethum Graveolens Extract and Atrovastatin against Candida Species Compared to Fluconazole (2013). 15. Antifungal effects of Echinophora platyloba on Biofilm formation of vaginal candida species, comparing to fluconazole (2013). 16. Relationship of Candida and Lactobacillus species in patients with candidal vaginitis compare to healthy individuals (2012). 17. Concentration of Aflatoxin M1 and Ochratoxin A in mothers milk in Khorrambid City, Fars, Iran, (2011). 18. Etiological survey of dermtophytosis in cattle farms in Isfahan (2001). 19. Etiological survey of mycotic infections of chronic mastitis in cattle farms in Isfahan (2001). 20. Evaluation of degree of adhesion of Candida albicans into four types of materials, used in denture base (1999). 21. Frequency of pulmonary fungal isolates in patients suspected to tuberculosis, in

Isfahan (1997). 22. Isolation of S.schenckii of the soil and plants in Isfahan, Iran (1997). 23. The therapeutic effects of oral Itraconazol on tinea capitis (1994). 24. The therapeutic effects of oral Itraconazol on dermatophytosis (1994). Conference Presentations 1. Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration (MIC) to fluconazole4 th World Congress and Expo on Applied Microbiology, September 19-21, 2016 Las Vegas, USA 2. Prevalence of cutaneous fungal infections and antifungal drug susceptibility of the isolates in patients with diabetes mellitus.2nd International and 4th Iranian Congress in Mediccal Mycology18th-20 Nov 2015 Shiraz Iran. 3. Aspergillus section flavi; morphologic, clinical aspects and extrolite production. World Congress and Expo on Applied Microbiology (350th OMICS International Conference. 18-20 August,2015, Frankfurt Germany. 4. Evaluation of infiltration with important acquired immune cells in kidney and spleen of mouse model in groups affected by systemic candidiasis, treated by etanolic extract of Zataria. The 5th International Congress of Laboratory & Clinic Iran, 2012. 5. The concentration of aflatoxin M1 in the mothers milk in Khorrambid City, Fars, Iran. Second Iranian Congress on Medical Mycology 2012., Ahvaz Iran. 6. Study the relationship of Candida Species with Lactobacillus Species in patients with fungal vaginitis and healthy individuals. Second Iranian Congress on Medical Mycology, Ahvaz Iran, 2012 7. Prevalence of fungal elements in Isfahan swimming pools water. Secound Iranian Congress on Medical Mycology, 2012 Ahvaz Iran. 8. Characterization of Iranian clinical and environmental isolates belonging to the Aspergillus flavus species complex by microsatellite analysis. Oral presentation, 3-5 November 2010, MEEGID X Conference Amsterdam, The Netherlands.

9. Enumeration and identification of dust fungal elements producing due to inversion phenomenon in Isfahan city on December 2010. First Iranian Congress on Medical Mycology Sari May Iran.2011 10. Sclerotia production in clinical isolates of A.flavus in different culture media.5 th Congress of Parasitic Disease in Iran, 2005. 11. Dermatophytic Pseudomycetoma: A case report.6th internationalcongress of dermatology, Esfahan, Iran, 2001. Preparation of the culture media by legumes and effects of them on growth and identification of bacteria. Oral presentation, 4th congress of microbiology Iran, 2001. 12. The effects of oral Itraconazol on treatment of fungal infections in Isfahan. Eleventh Iranian Congress of Physiology & Pharmacology Tabriz, Iran, 1998. Fungal cutaneous infection among patients suspected of cutaneous leishmaniasis.x11 international congress for tropical medicine and malaria, 1988.